sk reduction 0.09, 0.05 to 0.14). Supplementation with Larginine plus antioxidant vitamins need to be further evaluated in a low-risk population in order for the firm conclusion to be drawn.
3.6.6. Plasma Volume Expansion
Blood plasma volume increases gradually in women during the second half of pregnancy and is reduced in women with pre-eclampsia  . It is possible that women with pre-eclampsia might benefit from expanded plasma volume if it were to increase blood circulation for the mother and baby. However, the results of a systematic review  are inconclusive about the effects of plasma volume expansion for the treatment of women with pre-eclampsia.
3.6.7. Cigarette Smoking
Cigarette smoking adversely affects every organ system  . However, very strangely, smoking during pregnancy has been associated with a reduction in the risk of pre-eclampsia in  .
The relation between smoking and pre-eclampsia was studied in a review  , conducted from 1959 to March 2006 with a total of 48 epidemiological studies. Overall, smoking during pregnancy reduces the risk of pre-eclampsia by up to 50% with a dose-response pattern. This result was consistent with all nulliparous and multiparas women, singleton and multifetal pregnancies, and in all cases of mild and severe pre-eclampsia. However, the underlying mechanisms and the exact ingredients in cigarette smoke that influence the risk of pre-eclampsia is unclear. However, given the other harmful effects of smoking, this cannot be generally considered a prevention method for pre-eclampsia. Further research and more epidemiological studies are needed to enhance our understanding of the disease and to clarify this puzzling relationship.
3.6.8. Low-Dose Dopamine
The role of low-dose dopamine in the management of pregnant women with severe pre-eclampsia was assessed in a systematic review in  . Only one Randomized placebo-controlled trial of six hours’ duration, including 40 postpartum women, was found. However, it remained unclear whether low-dose dopamine therapy for pre-eclamptic women with oliguria is beneficial.
According to one theory the shortage of progesterone might be the cause of preeclampsia, hence it is believed that progesterone during pregnancy might help them to avoid pre-eclampsia. However, no reliable conclusions could be made about the effects of progesterone in preventing pre-eclampsia and its complications according to the result of a review in  .
3.6.10. Thiazide Diuretics
Diuretic drugs result in reducing the blood pressure by excreting more urine and hence relaxing blood vessels. Due to these effects, it has been believed that Diuretic drugs might lower the risk of pre-eclampsia in pregnant women. However, the result drew in a systematic review  (5 studies involving 1,836 women), showed insufficient evidence to draw reliable conclusions about the effects of diuretics on prevention of pre-eclampsia and its related complications. The risk of nausea and vomiting was also increased, therefore the use of diuretics for the prevention of pre-eclampsia and its related complications cannot be suggested.
3.6.11. Antioxidant Oral Lycopene
A randomized double-blind placebo-controlled trial  with 159 primigravidas (similar physical and social parameters) was conducted in India to evaluate the efficacy of antioxidant lycopene in preventing pre-eclampsia. 77 women received 2mg/day oral lycopene until delivery. There was no significant difference in developing pre-eclampsia. The results confirm that lycopene is not effective in preventing pre-eclampsia in healthy primigravidas. Rather, they result in the incidence of the adverse effects of preterm labor and low birth weight babies.
There are many medications and techniques that have been identified and assessed for its role in the prevention of pre-eclampsia and eclampsia. Magnesium sulfate so far has shown a great success in this regard and can be called as treatment of choice. It is more effective than diazepam, phenytoin, aspirin, calcium supplementation or lytic cocktail. However, despite the strong evidence, trials comparing alternative techniques are too small for reliable conclusions. There is insufficient evidence to show what the best dose and route of magnesium sulfate for women with pre-eclampsia or eclampsia are.
Similarly, the role of aspirin, calcium supplementation, and L-arginine plus antioxidant vitamins continues to be controversial. Its benefits and effectiveness range from small to moderate depending on the outcome. Further research is needed to assess which women are most likely to benefit. There is also insufficient evidence about whether to recommend rest or increased physical activity to women during pregnancy. Further research is highly desirable in different settings to explain its role in the development and prevention of pre-eclampsia and its complications.
There is evidence in the light of the included studies in this review as well as previous studies that supplementation with vitamins C and E did not reduce the risk of pre-eclampsia in both nulliparous and multiparous women. However, further research is needed to analyze the possibility that vitamin supplementation might be helpful in women with a low antioxidant status.
Another puzzling evidence we obtained from this review is that smoking during pregnancy reduces the risk of pre-eclampsia by up to 50% with a dose response pattern. This result was consistently found in nulliparous and multiparas, singleton and multifetal pregnancies for both mild and severe preeclampsia. Current literature does not give us a clear explanation for this supportive effect of smoking in pregnant women. However, considering its harmful effects, smoking cannot be considered as a prevention method for pre-eclampsia. Further research and more epidemiological studies are needed to enhance our understanding of the disease and to clarify this puzzling relationship.
Moreover, there are no systematic reviews and control trails based on immediate delivery of the baby (the definitive treatment for pre-eclampsia and eclampsia) and another important standard-of-care treatment (non-diuretic anti-hypertensives).
We also recommend further research into assessing the role and importance of current and new technologies and techniques in the reduction of pre-eclampsia and eclampsia. All nurses or midwives should know the evidence about the prevention and treatment of pre-eclampsia and eclampsia to identify the nursing care that is essential to guide the pregnant woman and family and prevent adverse events related to the use of preferred techniques and medications.
We wish to thank The World Academy of Sciences (TWAS), Italy and the National Council for Scientific and Technological Development (CNPq), Brazil for their financial assistance.
Conflicts of Interest
The authors declare no conflicts of interest.
|||Duley, L., Henderson-Smart, D.J. and Walker, G.J.A. (2009) Interventions for Treating Pre-Eclampsia and Its Consequences: Generic Protocol. The Cochrane Library, Hoboken.|
|||World Health Organization, et al. (2011) Who Recommendations for Prevention and Treatment of Pre-Eclampsia and Eclampsia. World Health Organization, Geneva.|
Khan, K.S., Wojdyla, D., Say, L., Gu¨lmezoglu, A.M. and Van Look, P.F.A. (2006) Who Analysis of Causes of Maternal Death: A Systematic Review. The Lancet, 367, 1066-1074.
|||WHO (2016) WHO Maternal Mortality, Geneva.|
|||Myles, M.F. (1993) Myles Textbook for Midwives, Volume 10. 12th Edition, Churchill Livingstone, Edinburgh.|
Ghulmiyyah, L. and Sibai, B. (2012) Maternal Mortality from Preeclampsia/Eclampsia. Seminars in Perinatology, 36, 56-59.
Duley, L. (2009) The Global Impact of Pre-Eclampsia and Eclampsia. Seminars in Perinatology, 33, 130-137.
Roberts, C.L., Ford, J.B., Algert, C.S., Antonsen, S., Chalmers, J., Cnattingius, S., Gokhale, M., Kotelchuck, M., Melve, K.K., Langridge, A., et al. (2011) Population-Based Trends in Pregnancy Hypertension and Pre-Eclampsia: An International Comparative Study. BMJ Open, 1, e000101.
Moher, D., Liberati, A., Tetzlaff, J., Altman, D.G. and The PRISMA Group (2009) Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The Prisma Statement. PLoS Med, 6, e1000097.
Niromanesh, S., Laghaii, S. and Mosavi-Jarrahi, A. (2001) Supplementary Calcium in Prevention of Pre-Eclampsia. International Journal of Gynecology & Obstetrics, 74, 17-21.
|||Duley, L., Henderson-Smart, D.J., Meher, S. and King, J.F. (2007) Antiplatelet Agents for Preventing Pre-Eclampsia and Its Complications (Review). Cochrane Database of Systematic Reviews, No. 2, CD004659.|
Belfort, M.A., Anthony, J., Saade, G.R. and Allen, J.C. (2003) A Comparison of Magnesium Sulfate and Nimodipine for the Prevention of Eclampsia. New England Journal of Medicine, 348, 304-311.
|||Duley, L., Gulmezoglu, A.M. and Chou, D. (2010) Magnesium Sulphate versus Lytic Cocktail for Eclampsia. The Cochrane Database of Systematic Reviews, No. 9, CD002960.|
|||Duley, L., Gulmezoglu, A.M., Henderson-Smart, D.J. and Chou, D. (2010) Magnesium Sulphate and Other Anticonvulsants for Women with Pre-Eclampsia. Cochrane Database of Systematic Reviews, No. 11, CD000025.|
Sibai, B.M. (1990) Magnesium Sulfate Is the Ideal Anticonvulsant in Preeclampsia-Eclampsia. American Journal of Obstetrics and Gynecology, 162, 1141-1145.
Coetzee, E.J., Dommisse, J. and Anthony, J. (1998) A Randomised Controlled Trial of Intravenous Magnesium Sulphate versus Placebo in the Management of Women with Severe Pre-Eclampsia. BJOG: An International Journal of Obstetrics & Gynaecology, 105, 300-303.
The Eclampsia Trial Collaborative Group (1995) Which Anticonvulsant for Women with Eclampsia? Evidence from the Collaborative Eclampsia Trial. The Lancet, 345, 1455-1463.
Chowdhury, J.R., Chaudhuri, S., Bhattacharyya, N., Biswas, P.K. and Panpalia, M. (2009) Comparison of Intramuscular Magnesium Sulfate with Low Dose Intravenous Magnesium Sulfate Regimen for Treatment of Eclampsia. Journal of Obstetrics and Gynaecology Research, 35, 119-125.
Rantonen, T., Kaapa, P., Gronlund, J., Ekblad, U., Helenius, H., Kero, P. and Valimaki, I. (2001) Maternal Magnesium Sulfate Treatment Is Associated with Reduced Brain-Blood Flow Perfusion in Preterm Infants. Critical Care Medicine, 29, 1460-1465.
Villa, P.M., Kajantie, E., Raikkonen, K., Pesonen, A.-K., Hamalainen, E., Vainio, M., Taipale, P. and Laivuori, H. (2013) Aspirin in the Prevention of Preeclampsia in High-Risk Women: A Randomised Placebo-Controlled Predo Trial and a Meta-Analysis of Randomised Trials. BJOG: An International Journal of Obstetrics & Gynaecology, 120, 64-74.
Rotchell, Y.E., Cruickshank, J.K., Phillips Gay, M., Griffiths, J., Stewart, A., Farrell, B., Ayers, S., Hennis, A., Grant, A., Duley, L., et al. (1998) Barbados Low Dose Aspirin Study in Pregnancy (Blasp, a Randomised Trial for the Prevention of Pre-Eclampsia and Its Complications. BJOG: An International Journal of Obstetrics & Gynaecology, 105, 286-292.
Haapsamo, M., Martikainen, H., Tinkanen, H., Heinonen, S., Nuojua-Huttunen, S. and Rasanen, J. (2010) Low-Dose Aspirin Therapy and Hypertensive Pregnancy Complications in Unselected IVF and ICSI Patients: A Randomized, Placebo-Controlled, Double-Blind Study. Human Reproduction, 25, 2972-2977.
|||Subtil, D., Goeusse, P., Puech, F., Lequien, P., Biausque, S., Breart, G., Uzan, S., Marquis, P., Parmentier, D. and Churlet, A. (2003) Aspirin (100 mg) Used for Prevention of Pre-Eclampsia in Nulliparous Women: The Essai Régional Aspirine Mère-Enfant Study (Part 1). BJOG: An International Journal of Obstetrics & Gynaecology, 110, 475-484.|
Yu, C.K.H., Papageorghiou, A.T., Parra, M., Palma Dias, R. and Nicolaides, K.H. (2003) Randomized Controlled Trial Using Low-Dose Aspirin in the Prevention of Pre-Eclampsia in Women with Abnormal Uterine Artery Doppler at 23 Weeks’ Gestation. Ultrasound in Obstetrics & Gynecology, 22, 233-239.
Caritis, S., Sibai, B., Hauth, J., Lindheimer, M.D., Klebanoff, M., Thom, E., Vandorsten, P., Landon, M., Paul, R., Miodovnik, M., et al. (1999) Low-Dose Aspirin to Prevent Preeclampsia in Women at High Risk. Survey of Anesthesiology, 43, 24.
|||Livingston, J.C., Livingston, L.W., Ramsey, R., Mabie, B.C. and Sibai, B.M. (2003) Magnesium Sulfate in Women with Mild Preeclampsia: A Randomized Controlled Trial. Obstetrics & Gynecology, 101, 217-220.|
|||Duley, L., Matar, H.E., Almerie, M.Q. and Hall, D.R. (2010) Alternative Magnesium Sulphate Regimens for Women with Preeclampsia and Eclampsia. The Cochrane Database of Systematic Reviews, No. 8, CD007388.|
Chiaffarino, F., Parazzini, F., Paladini, D., Acaia, B., Ossola, W., Marozio, L., Facchinetti, F. and Del Giudice, A. (2004) A Small Randomised Trial of Low-Dose Aspirin in Women at High Risk of Preeclampsia. European Journal of Obstetrics & Gynecology and Reproductive Biology, 112, 142-144.
Sibai, B.M., Caritis, S.N., Thom, E., Klebanoff, M., McNellis, D., Rocco, L., Paul, R.H., Romero, R., Witter, F., Rosen, M., et al. (1993) Prevention of Preeclampsia with Low-Dose Aspirin in Healthy, Nulliparous Pregnant Women. New England Journal of Medicine, 329, 1213-1218.
Xu, H., Perez-Cuevas, R., Xiong, X., Reyes, H., Roy, C., Julien, P., Smith, G., von Dadelszen, P., Leduc, L., Audibert, F., et al. (2010) An International Trial of Antioxidants in the Prevention of Preeclampsia (Intapp). American Journal of Obstetrics and Gynecology, 202, 239.e1-239.e10.
Gulmezoglu, A.M., Hofmeyr, G.J. and Oosthuisen, M.M.J. (1997) Antioxidants in the Treatment of Severe Pre-Eclampsia: An Explanatory Randomised Controlled Trial. British Journal of Obstetrics and Gynaecology, 104, 689-696.
Villar, J., Purwar, M., Merialdi, M., Zavaleta, N., Anthony, J., De Greeff, A., Poston, L., Shennan, A., et al. (2009) World Health Organisation Multicentre Randomised Trial of Supplementation with Vitamins c and e among Pregnant Women at High Risk for Pre-Eclampsia in Populations of Low Nutritional Status from Developing Countries. BJOG: An International Journal of Obstetrics & Gynaecology, 116, 780-788.
|||Rumbold, A., Duley, L., Crowther, C.A. and Haslam, R.R. (2008) Antioxidants for Preventing Pre-Eclampsia. The Cochrane Database of Systematic Reviews, No. 4, CD004227.|
McCance, D.R., Holmes, V.A., Maresh, M.J.A., Patterson, C.C., Walker, J.D., Pearson, D.W.M., Young, I.S., et al. (2010) Vitamins c and e for Prevention of Pre-Eclampsia in Women with Type 1 Diabetes (Dapit, a Randomised Placebo-Controlled Trial. The Lancet, 376, 259-266.
|||Rumbold, A.R., Crowther, C.A., Haslam, R.R., Dekker, G.A. and Robinson, J.S. (2006) Vitamins c and e and the Risks of Preeclampsia and Perinatal Complications. New England Journal of Medicine, 354, 1796-1806.|
Poston, L., Briley, A.L., Seed, P.T., Kelly, F.J., Shennan, A.H., et al. (2006) Vitamin c and vitamin e in Pregnant Women at Risk for Pre-Eclampsia (Vip Trial, Randomised Placebocontrolled Trial. The Lancet, 367, 1145-1154.
Roberts, J.M., Myatt, L., Spong, C.Y., Thom, E.A., Hauth, J.C., Leveno, K.J., Pearson, G.D., Wapner, R.J., Varner, M.W., Thorp, J.M., et al. (2010) Vitamins c and e to Prevent Complications of Pregnancy-Associated Hypertension. New England Journal of Medicine, 362, 1282-1291.
Spinnato, J.A., Freire, S., Pinto e Silva, J.L., Rudge, M.V.C., Martins-Costa, S., Koch, M.A., Goco, N., de Barros Santos, C., Cecatti, J.G., Costa, R., et al. (2007) Antioxidant Therapy to Prevent Preeclampsia: A Randomized Controlled Trial. Obstetrics & Gynecology, 110, 1311-1318.
|||Villar, J. and Belizan, J.M. (2000) Same Nutrient, Different Hypotheses: Disparities in Trials of Calcium Supplementation during Pregnancy. The American Journal of Clinical Nutrition, 71, 1375s-1379s.|
Villar, J., Abdel-Aleem, H., Merialdi, M., Mathai, M., Ali, M.M., Zavaleta, N., Purwar, M., Hofmeyr, J., Campodonico, L., Landoulsi, S., et al. (2006) World Health Organization Randomized Trial of Calcium Supplementation among Low Calcium Intake Pregnant Women. American Journal of Obstetrics and Gynecology, 194, 639-649.
Levine, R.J., Hauth, J.C., Curet, L.B., Sibai, B.M., Catalano, P.M., Morris, C.D., DerSimonian, R., Esterlitz, J.R., Raymond, E.G., Bild, D.E., et al. (1997) Trial of Calcium to Prevent Preeclampsia. New England Journal of Medicine, 337, 69-77.
Hofmeyr, G.J., Duley, L. and Atallah, A. (2007) Dietary Calcium Supplementation for Prevention of Pre-Eclampsia and Related Problems: A Systematic Review and Commentary. BJOG: An International Journal of Obstetrics & Gynaecology, 114, 933-943.
|||Meher, S. and Duley, L. (2006) Exercise or Other Physical Activity for Preventing Pre-Eclampsia and Its Complications. The Cochrane Database of Systematic Reviews, No. 2, CD005942.|
Yeo, S. (2009) Adherence to Walking or Stretching, and Risk of Preeclampsia in Sedentary Pregnant Women. Research in Nursing & Health, 32, 379-390.
|||Meher, S. and Duley, L. (2006) Rest during Pregnancy for Preventing Preeclampsia and Its Complications in Women with Normal Blood Pressure. The Cochrane Database of Systematic Reviews, No. 2, CD005939.|
|||Duley, L., Henderson-Smart, D.J. and Meher, S. (2005) Altered Dietary Salt for Preventing Pre-Eclampsia, and Its Complications. The Cochrane Database of Systematic Reviews, No. 4, CD005548.|
|||Li, W., Tang, L., Wu, T., Zhang, J., Liu, G.J. and Zhou, L. (2006) Chinese Herbal Medicines for Treating Pre-Eclampsia. The Cochrane Database of Systematic Reviews, No. 2, CD005126.|
|||Makrides, M., Duley, L. and Olsen, S.F. (2006) Marine Oil, and Other Prostaglandin Precursor, Supplementation for Pregnancy Uncomplicated by Pre-Eclampsia or Intrauterine Growth Restriction. The Cochrane Database of Systematic Reviews, No. 3, CD003402.|
Zhou, S.J., Yelland, L., McPhee, A.J., Quinlivan, J., Gibson, R.A. and Makrides, M. (2012) Fish-Oil Supplementation in Pregnancy Does Not Reduce the Risk of Gestational Diabetes or Preeclampsia. The American Journal of Clinical Nutrition, 95, 1378-1384.
|||Meher, S. and Duley, L. (2006) Garlic for Preventing Pre-Eclampsia and Its Complications. The Cochrane Database of Systematic Reviews, No. 3, CD006065.|
Lees, C., Valensise, H., Black, R., Harrington, K., Byiers, S., Romanini, C. and Campbell, S. (1998) The Efficacy and Fetal-Maternal Cardiovascular Effects of Transdermal Glyceryl Trinitrate in the Prophylaxis of Pre-Eclampsia and Its Complications: A Randomized Double-Blind Placebo-Controlled Trial. Ultrasound in Obstetrics & Gynecology, 12, 334-338.
|||Meher, S. and Duley, L. (2007) Nitric Oxide for Preventing Pre-Eclampsia and Its Complications. The Cochrane Database of Systematic Reviews, No. 2, CD006490.|
|||Vadillo-Ortega, F., Perichart-Perera, O., Espino, S., Avila-Vergara, M.A., Ibarra, I., Ahued, R., Godines, M., Parry, S., Macones, G., Strauss, J.F., et al. (2011) Effect of Supplementation during Pregnancy with l-Arginine and Antioxidant Vitamins in Medical Food on Pre-Eclampsia in High Risk Population: Randomised Controlled Trial. BMJ, 342, d2901.|
|||Duley, L., Williams, J. and Henderson-Smart, D.J. (2000) Plasma Volume Expansion for Treatment of Women with Pre-Eclampsia. The Cochrane Database of Systematic Reviews, No. 2, CD001805.|
Shea, A.K. and Steiner, M. (2008) Cigarette Smoking during Pregnancy. Nicotine & Tobacco Research, 10, 267-278.
|||England, L. and Zhang, J. (2007) Smoking and Risk of Preeclampsia: A Systematic Review. Frontiers in Bioscience, No. 12, 2471-2483.|
|||Wilhelm Steyn, D. and Steyn, P. (2007) Low-Dose Dopamine for Women with Severe Pre-Eclampsia. The Cochrane Database of Systematic Reviews, No. 1, CD003515.|
|||Meher, S. and Duley, L. (2009) Progesterone for Preventing Pre-Eclampsia and Its Complications.|
|||Churchill, D., Beevers, G.D.G., Meher, S. and Rhodes, C. (2007) Diuretics for Preventing Pre-Eclampsia. The Cochrane Database of Systematic Reviews, No. 1, CD004451.|
Banerjee, S., Jeyaseelan, S. and Guleria, R. (2009) Trial of Lycopene to Prevent Pre-Eclampsia in Healthy Primigravidas: Results Show Some Adverse Effects. Journal of Obstetrics and Gynaecology Research, 35, 477-482.
Copyright © 2020 by authors and Scientific Research Publishing Inc.
This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.